ALLMedicine™ Malignant Melanoma Center
Research & Reviews 2,634 results
https://doi.org/10.1097/CMR.0000000000000828
Melanoma Research; Seyed Jafari SM, Mazinani M et. al.
May 18th, 2022 - Locoregional and distant metastases account for most cases of morbidity and mortality associated with melanoma. In addition, local recurrences of melanoma might be the onset of disseminated disease. Therefore, precise diagnosis and therapy are war...
https://doi.org/10.1111/jdv.18217
Journal of the European Academy of Dermatology and Venere... Kleemann J, Meissner M et. al.
May 17th, 2022 - SARS-CoV-2 has massively changed the care situation in hospitals worldwide. Although tumor care should not be affected, initial reports from European countries were suggestive for a decrease in skin cancer during the first pandemic wave and only l...
https://doi.org/10.1111/odi.14252
Oral Diseases; Kodama T, Shigeoka M et. al.
May 15th, 2022 - The significance of intratumoural CD163+ macrophages in oral malignant melanoma: A preliminary study.|2022|Kodama T,Shigeoka M,Nishio M,Koma YI,Akashi M,|
https://clinicaltrials.gov/ct2/show/NCT02133196
May 13th, 2022 - Background: Patients with metastatic non-small cell lung cancer (NSCLC) have few approved therapeutic options and those that exist are of transient benefit. Recent clinical experiences with experimental agents that release checkpoints on the host ...
https://clinicaltrials.gov/ct2/show/NCT05019534
May 12th, 2022 - BRAF mutation exists in about 10-12% of colorectal cancer, among which BRAF V600E mutation is the most common type, which is an important biomarker for predicting the prognosis and precise treatment efficacy of metastatic colorectal cancer (mCRC)....
Guidelines 2 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882649
International Journal of Clinical Oncology; Saito T, Tabata T et. al.
Nov 22nd, 2017 - Vulvar cancer and vaginal cancer are relatively rare tumors, and there had been no established treatment principles or guidelines to treat these rare tumors in Japan. The first version of the Japan Society of Gynecologic Oncology (JSGO) guidelines...
https://doi.org/10.1093/annonc/mdn100
Annals of Oncology : Official Journal of the European Soc... Dummer R, Hauschild A et. al.
May 9th, 2008 - Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.|2008|Dummer R,Hauschild A,Jost L, ,|diagnosis,epidemiology,pathology,therapy,diagnosis,epidemiology,pathology,therapy,
Drugs 9 results see all →
Clinicaltrials.gov 109 results
https://clinicaltrials.gov/ct2/show/NCT02133196
May 13th, 2022 - Background: Patients with metastatic non-small cell lung cancer (NSCLC) have few approved therapeutic options and those that exist are of transient benefit. Recent clinical experiences with experimental agents that release checkpoints on the host ...
https://clinicaltrials.gov/ct2/show/NCT05019534
May 12th, 2022 - BRAF mutation exists in about 10-12% of colorectal cancer, among which BRAF V600E mutation is the most common type, which is an important biomarker for predicting the prognosis and precise treatment efficacy of metastatic colorectal cancer (mCRC)....
https://clinicaltrials.gov/ct2/show/NCT02410733
Apr 26th, 2022 - The Lipo-MERIT vaccine consists of four naked ribonucleic acid (RNA)-drug products (DPs) that are optimized to induce antigen-specific cluster of differentiation (CD)8+ and CD4+ T cell responses against the four selected malignant melanoma-associa...
https://clinicaltrials.gov/ct2/show/NCT02906943
Apr 22nd, 2022 - A recent survey of clinical genetic testing laboratories for cancer diagnostics by the Molecular Oncology Advisory Committee for Cancer Care Ontario identified disparities in access and use patterns for next generation sequencing (NGS) across the ...
https://clinicaltrials.gov/ct2/show/NCT04056247
Apr 19th, 2022 - The goal of this research study is to develop an algorithm that predicts the patient's treatment outcome.This algorithm will serve as a tool for physicians when making treatment decisions, specifically for stage IV NSCLC and malignant melanoma pat...
News 251 results
https://www.medscape.com/viewarticle/969171
Apr 6th, 2022 - The Skill Checkup series provides a quick, case-style interactive quiz highlighting key guidelines- and evidence-based information to inform clinical practice. A 73-year-old woman presented for follow-up of malignant melanoma. The melanoma was res...
https://www.medscape.com/viewarticle/970581
Mar 18th, 2022 - Immune checkpoint inhibitors (ICIs) have unquestionably revolutionized the care of patients with malignant melanoma, non-small cell lung cancer, and other types of cancer. But about 40% of patients with cancer treated with ICIs will experience imm...
https://www.medscape.com/viewarticle/966638
Feb 23rd, 2022 - Malignant melanoma is the third most common cutaneous cancer after basal cell carcinoma and squamous cell carcinoma. Although most malignant melanomas are diagnosed at an early stage, this cancer also has the inherent ability to spread aggressivel...
https://www.medscape.com/viewarticle/966637
Feb 22nd, 2022 - Malignant melanoma is the fifth most common cancer, with an estimated 106,110 new cases in the United States in 2021. The incidence of malignant melanoma has been on the rise globally and trails only lung cancer in women in terms of the rate of in...
https://www.mdedge.com/dermatology/article/251392/wounds/pencil-core-granuloma-forming-62-years-after-initial-injury
Blake R. Zelickson, MD, PhD, Leonard H. Goldberg, MD et. al.
Feb 3rd, 2022 - To the Editor: Trauma from a pencil tip can sometimes result in a fragment of lead being left embedded within the skin. Pencil lead is composed of 66% graphite carbon, 26% aluminum silicate, and 8% paraffin.